書籍詳細

1. 錐体外路系(基底核) 疾患

P.15 掲載の参考文献

• 1) Delay, J. and Deniker, P.:Sur quelques errurs de prescription des medicaments psychiatriques. Bull. Mem. Soc. Med. Hop. Paris 116:487-493, 1965

• 2) Toru, M., Matsuda, O., Makiguchi, K. et al.:Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs. J. Nerv. Ment. Dis. 169:324-327, 1981
  pubmed

• 3) 藤竹純子, 久野貞子, 西谷裕:「悪性症候群」様状態を呈したパーキンソニズム8例の検討. 臨床神経学 24:371-378, 1984

P.17 掲載の参考文献

• 1) 平井俊策:パーキンソン病. 現代医療 10:647-653, 1978

• 2) Schwab, R. S., England, A. C. Jr., Pospanzer, D. C. et al.:Amantadine in the treatment of Parkinson's disease. JAMA 208:1108, 1969

• 3) Pearce, J.:Trial of combination with anticholinergic drugs and L-dopa. In:"Parkinson's Disease", ed. by Birwood, G. F. B., Gilder, S. S. B. and Wink, C. A. S., Academic Press London, 1971, p. 45

• 4) Gillard, O.:Swedish double-blind crossover trial. In:"Parkinson's Disease", ed. by Birwood, G. F. B., Gilder, S. S. B. and Wink, C. A. S., Academic Press, London, 1971, p. 12

• 5) 大友英一, 笹生俊一, 荒木五郎ほか:脳血管障害例の各種精神症状に対するSymmetrel (Amantadine hydrochloride) の薬効評価-Placeboを対照とした多施設二重盲検法による調査-. Clin. Eval. 12:321-367, 1984

P.19 掲載の参考文献

• 1) Morita, H., Ikeda, S., Yamamoto, K. et al.:Hereditary ceruloplasmin deficiency with hemosiderosis:a clinicopathological study of a Japanese family. Ann. Neurol. 37:646-656, 1995
  pubmed

• 2) Morita, H. and Yanagisawa, N.:The role of ceruloplasmin for iron and copper metabolism in central nervous system disorders. In:Mineral and Metal Neurotoxicology, ed. by Yasui, M., Strong, M. J., Ota, K. et al., CRC Press, Florida, 1996, pp. 405-411

• 3) Yoshida, K., Furihata, K, Takeda, S. et al.:A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nature Genet. 9:267-272, 1995
  pubmed

• 4) Harris, Z. L., Morita, H. and Gitlin, J. D.:The biology of human ceruloplasmin. In:The Multi Copper Oxidases, ed. by Messerschmidt, A., World Scientific Publishing, Singapore, 1997 (in press)

P.21 掲載の参考文献

• 1) 水野美邦:パーキンソン病に対する levodopa 長期治療の問題点. 日内会誌, 71:1553-1559, 1988

• 2) Fabbrin, G., Mouradian, M. M., Juncos, J. L. et al.:Motor fluctuation in Parkinson's disease:central pathophysiological mechanisms, Part I. Ann. Neurol. 24:366-371, 1988

• 3) Tohgi, H., Abe, T., Yamazaki, K. et al.:Effects of the catechol-O-methyltransferase inhibitor tolcapone in Parkinson's disease:correlations between concentrations of dopaminergic substances in the plasma and cerebrospinal fluid and clinical improvement. Neurosci. Lett. 192:165-168, 1995
  pubmed

P.25 掲載の参考文献

• 1) Mannisto, P. T. and Kaakkola, S.:New selective COMT inhibitors:useful adjuncts for Parkinson's disease? TIPS 10:54-56, 1989
  pubmed

• 2) Nutt, J. G.:Effects of catechol-O-metyltransferase (COMT) inhibition on the pharmacokinetics of L-DOPA. in:Advanced Neurology, ed. by Battistin, L., Scarlato, G., Caraceni, T.et al., Lippincott-Raven Publishers, Philadelphia, 1996, pp. 493-496

P.27 掲載の参考文献

• 1) 塩沢瞭一:アマンタジンおよび抗コリン剤の使い方. 医学と薬学 13:263-269, 1985
  Medical*Online

• 2) Textbook of Clinical Neuropharmacology and Therapeutics. 2nd Edition, ed. by Klawans, H.L., Goetz, C. G. and Tanner, C.M., Raven Press, New York, 1992

• 3) 小川紀雄:アセチルニリン系と薬物療法. 神経治療 9:431-434, 1992

• 4) 精神科薬物療法ハンドブック. 神庭重信, 八木剛平監訳, 医学書院 MYW, 東京, 1994

• 5) 小川紀雄, 山本光利:神経内科の処方設計増補版, 医歯薬出版, 東京, 1996

P.29 掲載の参考文献

• 1) Svennilson, E., Torvik, A., Lowe, R. et al.:Treatment of parkinsonism by stereotactic thermolesions in the pallidal region. Acta Psychiatr. Neurol. Scand. 35:358-377, 1960

• 2) Laitinen, LV., Bergenheim, A. T. and Hariz, M.I.:Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J. Neurosurg. 76:53-61,1992
  pubmed

• 3) Shima, F., Ishido, K., Sun. S.-J. et al.:Surgical control of akinesia in Parkinson's disease. Eur. Neurol. 36:55-61, 1996
  pubmed

P.31 掲載の参考文献

• 1) Mogi, M., Harada, M., Kondo, T. et al.:Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients. Neurosci. Lett. 180:147-150, 1994

• 2) Mogi, M., Harada, M., Kondo, T. et al.:Transforming growth factor-β1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease. Neurosci. Lett. 193:129-132, 1995

• 3) Mogi, M., Harada, M, Kondo, T. et al.:bcl-2 protein is increased in the brain from parkinsonian patients. Neurosci. Lett. 215:137-139, 1996
  pubmed

• 4) Mogi, M., Harada, M., Kondo, T. et al.:The soluble form of Fas molecule is elevated in parkinsonian brain tissues. Neurosci. Lett. 220:195-198, 1996
  pubmed

P.33 掲載の参考文献

• 1) Halliwell, B.:Reactive oxygen species and the central nervous system. J. Neurochem. 59:1609-1623, 1992
  pubmed

• 2) Youdim, M. B. H. and Riederer, F.:The role of iron in senescence of dopaminergic neurons in Parkinson's disease. J. Neural Transm. Suppl. 40:57-67, 1995

• 3) Bindoll, A., Rigobello, M. P. and Deeble, D. J.:Biochemical and toxicological properties of the oxidation products of catecholamines. Free Rad. Biol. Med. 13:391-405, 1992
  pubmed

• 4) Naoi, M., Maruyama, W., Dostert, P. et al.:N-Methyl-(R) salsolinol as dopaminergic neurotoxin:from an animal model to an early marker of Parkinson's disease. J. Neural Transm. Suppl. 50:89-105, 1996

• 5) Maruyama, W., Nakahara, D., Dostert, P. et al.:Dopamine-derived isoquinolines as dopaminergic neurotoxins and oxidative stress. In:Alzheimer's and Parkinson's Diseases, ed. by Hanin, I. et al., Plenum Press, New York, 1995, pp. 575-581

P.35 掲載の参考文献

• 1) Duch, D. S. and Smith, G. K.:Biosynthesis and function of tetrahydrobiopterin. J. Nutr Biochem. 2:411-423, 1991

• 2) Ichinose, H., Ohye, T., Takahashi, E. et al.:Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nature Genet. 8:236-242, 1994
  pubmed

• 3) Ichinose, H., Ohye, T., Matsuda, Y. et al.:Characterization of mouse and human GTP cyclohydrolase I genes:mutations in patients with GTP cyclohydrolase I deficiency. J. Biol. Chem. 270:0062-10071, 1995

P.37 掲載の参考文献

• 1) DeLong, M. R.:Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13:281-285, 1990
  pubmed

• 2) Mink, J. W. and Thach, W. T.:Basal ganglia intrinsic circuits and their role in behavior. Curr. Opin. Neurobiol. 3:950-957, 1993
  pubmed

P.39 掲載の参考文献

• 1) 横地正之:若年性パーキンソン病I-臨床的特徴-. 神経進歩 23:1048-1059, 1979

• 2) 横地正之:若年性パーキンソニズム. Annual Review 神経1990, 中外医学社, 東京, 1990, pp. 240-253

• 3) Quinn, N, Critchley, P., Marsden, C. D. et al.:Young onset Parkinson's disease. Mov. Disord. 2:73-91, 1987
  pubmed

• 4) Yokochi, M.:Juvenile parkinsonism and other dopa-responsive syndromes. In:Age-Related Dopamine-Dependent Disorders, ed. by Segawa, M. and Nomura, Y., Monogr Neural Sci, Basel, Karger, 1995, vol 14, pp. 25-35

• 5) 永津俊治, 一瀬宏:遺伝性ジストニアの分子遺伝学. 神経進歩 39:1036-1042, 1995

• 6) 石川厚:若年性パーキンソニズムの臨床. 脳神経 46:517-522, 1994

• 7) 山村安弘, 群山達男:日内変動を呈する常染色体劣性若年発症パーキンソニズムー臨床像の検討-. 臨床神経学 36:944-950, 1996

P.41 掲載の参考文献

• 1) 平井俊策:フリーラジカルの発生と神経細胞死. Clin. Neurosci. 27:983-985, 1994

• 2) Gerlach, M., Ben-Shachar, Riederer, P. et al.:Altered brain metabolism of iron as a cause of neurodegenerative diseases. J. Neurochem. 63:793-807, 1994
  pubmed

• 3) Olanow, C. W.:An introduction to the free radical hypothesis in Parkinson's disease. Ann. Neurol 32:S2-S9, 1992

P.43 掲載の参考文献

• 1) 今井壽正, 楢林博太郎:アキネジア-純粋アキネジアの2症例を中心にして. 神経進歩 24:787-794, 1974

• 2) 今井壽正:純粋無動症. Annual Review 神経1996, 中外医学社, 東京, 1996, pp. 189-197

• 3) Riley D. E., Fogt, N. and Leigh, R. J.:The syndrome of 'pure akinesia' and its relationship to progressive supranuclear palsy. Neurology 44:1025-1029, 1994
  pubmed

P.45 掲載の参考文献

• 1) Shapiro, A. K. Shapiro E. S., Young, J. G. et al.:Tourette's Syndrome, 2nd ed., Raven Press, New York, 1988, pp. 45-59

• 2) Leckman, J. F.:The Pathogenesis of Tourette's syndrome:role of biogenic amines and sexually dimorphic systems active in early CNS development. In:Age-Related Dopamine-Dependent Disorders, ed. by Segawa, M. and Nomura Y., Karger, Basel, 1995, pp. 41-49

• 3) 野村芳子:不随意運動を主とする変性疾患 Gilles de la Tourette 症候群. 最新内科学大系第68巻神経変性疾患, 中山書店, 東京, 印刷中

P.47 掲載の参考文献

• 1) Steele, J. C., Richardson, J. C. and Olszewski, J.:Progressive supranuclear palsy. Arch. Neurol. 10:333-359, 1964
  pubmed

• 2) Tolosa, E, Valldeoriola, F. and Marti, M. J.:Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy. J. Neural. Transm. (suppl.) 42:15-31, 1994
  pubmed

• 3) 中村利生, 今井壽正:進行性核上性麻痺. 日本臨淋 55:1997

P.48 掲載の参考文献

• 1) 上野エリ子:パーキンソン病の歩行障害-小歩症, すくみ足, 歩行失行-. 脳神経 43:720-729, 1991

• 2) Gerstmann, J., and Schilder, P.:Uber eine basondere Gangstorung bei Stirnhirn-Erkrankung. Wien. Med. Wochenschr. 76:97-102, 1926

• 3) Bruns, L.:Ueber Storung des Gleichgewichtes bei Stirnhirntumoren. Dtsch. Med. Wochenschr. 18:138-140, 1892

• 4) Van Bogaert, L. and Martin, P:L'apraxie de la marche et l'atonie statique. Encephale 24:11-18, 1929

• 5) Meyer, J. S., and Barron, D. W.:Apraxia of gait:a clinicopathological study. Brain 83:261-284, 1960

• 6) Petrovici, I.:Apraxia of gait and trunk movement. J. Neurol. Sci. 7:229-243, 1968
  pubmed

P.55 掲載の参考文献

• 1) Segawa, M., Nomura, Y. and Kase, M.:Diurnal fluctuating hereditary progressive dystonia. In:Handbook of Clinical Neurology, ed. by Vinken, P. J., Bruyn, G. W. and Klawans, H. L, Elsevier, Amsterdam, 1986, Vol. 5(49), pp. 529-539

• 2) Ichinose, H., Ohye, T., Takahashi, E. et al.:Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nature Genet. 8:236-242, 1994
  pubmed

• 3) Rajput, A. H., Gibb, W., Kish, S. et al.:Dopa-responsive dystonia:clinical, pathological and bio-chemical studies in one case. Mov. Disord. 7(suppl.1):124, 1992

• 4) 藤田繁, 新宅治夫:著明な日内変動を伴う遺伝性進行性ジストニア (HPD:瀬川病):の病因とプテリジン代謝異常. 市立釧路医誌 2:64-67, 1990

• 5) Furukawa, Y., Nishi, K., Kondo, T. et al.:CSF biopterin levels and clinical features of patients with juvenile parkinsonism. In:Advances in Neurology, ed. by Narabayashi, H., Nagatsu, T., Yanagisawa, N. et al., Raven Press, New York, 1993, Vol. 60, pp. 562-567

• 6) Segawa, M. and Nomura, Y.:Hereditary progressive dystonia with marked diurnal fluctuation and dopa-responsive dystonia:pathognomonic clinical features. In:Age Related Dopamine-Dependent Disorders, ed. by Segawa, M. and Nomura, Y., Monogr Neural Sci, Basal., 1995, vol. 14, pp. 10-24

• 7) 瀬川昌也, 西山信女子:ビオプテリン代謝障害-著明な日内変動を伴う遺伝性進行性ジストニア. medicina 33:787-793, 1996

• 8) Antonini, A., Leenders, K. L, Reist, H. et al.:Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C raclopride. Arch. Neurol 50:474-480, 1993
  pubmed

P.57 掲載の参考文献

• 1) Yoshida, K., Furihata, K, Takeda, S. et al.:A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nature Genet. 9:267-272, 1995
  pubmed

• 2) Daimon, M., Yamatani, K., Igarashi, M. et al.:Fine structure of the human ceruloplasmin gene. Biochem. Biophys. Res. Commun. 208:1028-1035, 1995
  pubmed

• 3) Klomp, L. W. J., Farhangrazi, Z. S., Dugan, L. L. et al.:Ceruloplasmin gene expression in the murine central nervous system. J. Clin. lnvest. 98:207-215, 1996

• 4) Zaitseva, I., Zaitsev, V., Card, G. et al.:The nature of the copper centres in human ceruloplasmin. J. Biol. Inorg. Chem. 1:15-23, 1996

• 5) Morita, H. and Yanagisawa, N.:The role of ceruloplasmin for iron and copper metabolism in central nervous system disorders, In:Mineral and Metal Neurotoxicology:ed. by Yasui, M., Strong, M., J., Ota, K. et al., CRC Press, Florida, 1996, pp, 405-411

P.59 掲載の参考文献

• 1) Damier, P., Kastner, A., Agid, Y. et al.:Dose monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease? Neurology 46:1262-1269, 1996

• 2) Heikkila, R. E, Manzino, L, Cabbat, F. S. et al.:Protection against the dopaminergic neurotoxicity of 1-methyl-4-pheny-1, 2, 3, 6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311:467-469, 1984

• 3) Parkinson Study Group:Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa. Ann. Neurol. 39:29-36, 1996

• 4) Ansari, K. S., Yu, P. H., Kruck, T. P. A. et al.:Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl:stereospecificity and independence from monoamine oxidase inhibition. J. Neurosci 13:4042-4053, 1993

• 5) Iwasaki, Y., Ikeda, K., Shiojima, T. et al.:Deprenyl enhances neurite outgrowth in cultured rat spinal ventral horn neurons. J. Neuro. Sci. 125:11-13, 1994

• 6) Tatton, W. G., Ju, W. Y. L., Holland, D. P. et al.:(-)-deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis. J. Neurochem. 63:1572-1575, 1994

• 7) Less, A. J., on behalf of the Parkinson's Disease Research Group of the United Kingdom:Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. BMJ 311:1602-1607, 1995

P.61 掲載の参考文献

• 1) Fearnley, J. M. and Lees, A. J.:Striatonigral degeneration. A clinicopathological study. Brain 113:1823-1842, 1990
  pubmed

• 2) Nakazato, Y. and Suzuki, S.:Oligodendroglial microtubular tangles in multiple system atrophy. Neuropathology 16:145-150, 1996

• 3) Gidman, S., Sima, A. A. F., Junck, L. et al.:Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions. Ann. Neurol. 39:241-255, 1996

P.65 掲載の参考文献

• 1) Hikosaka, O. and Wurtz, R. H.:The basal ganglia. In:The Neurobiology Of Saccadic Eye Movements Vol 3, ed. by Wurtz, R. H. and Goldberg, M. E. EIsevier, Amsterdam, 1989, pp. 257-281

• 2) Kato, M. and Hikosaka, O.:Function of the in-direct pathway in the basal ganglion oculomotor system:visuo-oculomotor activities of external pallidum neurons. In:Age-Related Dopamine-Dependent Disorders, ed. by Segawa, M. and Nomura, Y., Monogr Neural Sci, Vol. 14, Basel, Karger, 1995, pp. 178-187

• 3) Yamamura, Y., Sobue, I., Ando, K. et al.:Paralysis agitans of early onset with marked diurnal fluctuation of symptoms. Neurology 23:239-244, 1973
  pubmed

• 4) 山村安弘, 郡山達男, 川上秀史ほか:日内変動を呈する常染色体劣性若年発症パーキンソニズム-臨床像の検討-. 臨床神経学 36:944-950, 1996

• 5) Hikosaka, O., Fukuda, H., Kato, M. et al.:Deficits in saccadic eye movements in hereditary progressive dystonia with marked diurnal fluctuation. In:Hereditary Progressive Dystonic with Marked Diurnal Fluctuation, ed. by Segawa, M., Parthenon, Carnforth, 1993, pp. 159-177

• 6) Segawa, M., Tanaka, R., Nomura, Y. et al.:Saccadic eye movements in basal ganglia disorders. In:Recent Advances in Clinical Neurophysiology, ed. by Kimura, J., Shibasaki, H., Elsevier, Amsterdam, 1996, pp. 170-176

• 7) Hikosaka, O., Tanaka, R., Fukuda, H. et al.:Abnormalities in visually guided and memory-guided saccades in Tourette Syndrome (under submission).

• 8) Sagawa, M. and Nomura, Y.:Hereditary progressive dystonia with marked diurnal fluctuation and dopa-responsive dystonia:pathognomonic clinical features. In:Age-Related Dopamine-Dependent Disorders, ed. by Segawa, M. and Nomura, Y., Monogr Neural Sci., Vol. 14. Basel, Karger, 1995, pp. 10-24

• 9) Fukuda, H., Segawa, M., Nomura, Y. et al.:Phasic activity during REM sleep in movement disorders. In:Age-Related Dopamine-Dependent Disorders, ed. by Segawa, M. and Nomura, Y., Monogr Neural Sci., Vol. 14. Basel, Karger, 1995, pp. 69-76

• 10) Wolf, S. S., Jones, D. W., Knable, M. B. et al.:Tourette syndrome:prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 273:1225-1227, 1996
  pubmed

• 11) Matsumine, H., Saito, M., Shimoda-Matsubayashi, S. et al.:Localization of a gene for an autosomal recessive form of juvenile parkinsonism to chromosome 6q 25. 5-27. Am. J. Hum. Genet. 60:588-596, 1997

P.67 掲載の参考文献

• 1) Dwork A. J., Schon, E. A. and Herbert, J.:Nonidentical distribution of transferrin and ferric iron in human brain. Neuroscience 27:333-345, 1988
  pubmed

• 2) Youdim, M. B. H., Ben-Shachar, D. and Riederer, P.:Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? Acta Neurol. Scand. 126:47-54, 1989

• 3) Jellinger, K. Paulus, W., Grundke-Iqbal, I. et al.:Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J. Neural Transm. 2:327-340, 1990

• 4) Good, P. F, Olanow, C. W. and Perl, D. P.:Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease:a LAMMA study. Brain Res. 593:343-346, 1992
  pubmed

• 5) Riederer, P., Sofic, E., Rausch, W.-D. et al.:Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. J. Neurochem. 52:515-520, 1989
  pubmed

P.69 掲載の参考文献

• 1) Alexander, G. E., DeLong, M. R. and Strick, P. L.:Parallel organization of functionally segregated circuit linking basal ganglia and cortex. Ann. Rev. Neurosci. 9:357-381, 1986
  pubmed

• 2) DeLong, M. R.:Primate models of movement disorders of basal ganglia origin. Trends in Neurosci. 13:281-285, 1990
  pubmed

• 3) Cummings, J. L.:Frontal-subcortical circuits and human behavior. Arch. Neurol. 50:873-880, 1993
  pubmed

P.71 掲載の参考文献

• 1) Rebeiz, J. J., Kolodny, E. H. and Richardson, E. P.:Corticodentatonigral degeneration with neuronal achromasia. Arch. Neurol. 18:20-33, 1968
  pubmed

• 2) Gibb, W. R. G., Luthert P. J. and Marsden, C. D.:Corticobasal degeneration. Brain 112:1171-1192, 1989

• 3) Riley, D. E., Lang, A. E., Lewis, A. et al.:Cortical-basal ganglionic degeneration. Neurology 40:1203-1212, 1990
  pubmed

• 4) Rinne, J. O., Lee, M. S., Thompson, P. D. et al.:Corticobasal degeneration. A clinical study of 36 cases. Brain 117:1183-1196, 1994
  pubmed

• 5) Feany, M. B., Mattiace, L. A. and Dickson, D. W.:Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J. Neuropathol. Exp. Neurol. 55:53-67, 1996
  pubmed

P.73 掲載の参考文献

• 1) Feinberg, T. E., Schindler, R. J., Flanagan, N. G. et al.:Two alien hand syndromes. Neurology 42:19-24, 1992

• 2) 河村満:「他人の手徴候」とその関連症候. 神経内科 36:555-560, 1992

• 3) 田中康文:他人の手徴候. 脳神経 48:229-238, 1996

• 4) Rinne, J. O., Lee, M. S., Thompson, P. D. et al.:Corticobasal degeneration:a clinical study of 36 cases. Brain 117:1183-1196, 1994
  pubmed

P.75 掲載の参考文献

• 1) Lantos, P. L.:The neuropathology of progressive supranuclear palsy. In:Progressive Supranuclear Palsy:Diagnosis, Pathology, and Therapy, ed, by Tolosa, E. and Duvoisin, R., Springer Verlag, Wien, 1994, pp. 137

• 2) Daniel, S. E., Bruin, V. M. S. et al.:The clinical and pathological spectrum of Steel-Richardson Olszewski syndrome (progressive supranuclear palsy):areappraisal. Brain 118:759, 1995

• 3)Contamine, F., Escourolle, R. et al.:Atrophie pallidonigro-luysienne syndrome akinetique avec pallilalie, rigidite opposition nelle et catatonie. Rev. Neurol. 124:107, 1971

• 4) Jellinger, K.:Pallidal, pallidonigral and pallidoluysionigral degenerations including association with thalamic and dentate degeneration. In:Handbook of Clinical Neurology, vol. 5, ed. by Vinken, P. J., Bruyn, G. W. et al., Elsevier Science, Amsterdam, 1986, p. 445

P.77 掲載の参考文献

• 1) Kalivas, P. W. and Barnes, C. D. (eds):Limbic Mo tor Circuits and Neuropschiatry. CRC Press, London, 1993, pp. 155-287

• 2) Le Moal, M. and Simon, H.:Mesocorticolimbic dopaminergic network:functional and regulatory roles. Physiol. Rev. 71:155-234, 1991
  pubmed

• 3) van Domburg, P. H. M. F. and ten Donkelaar, H. J.:The human substantia nigra and ventral tegmental area. Adv. Anat. Embryol. Cell Biol. 121:1-132, 1991

P.79 掲載の参考文献

• 1) Brossi, A.:Mammalian alkaloids II. In:The Alkaloids. Vol. 43, Academic Press, New York, 1993, pp. 119-183

• 2) 太田茂, 廣部雅昭:MPTP 様内因物質. Molecular Medicine 31:654-660, 1994

P.81 掲載の参考文献

• 1) ad hoc committee, World Federation of Neurology:Classification of extrapyramidal disorders. J. Neurol. Sci. 51:311-327, 1981

• 2) Fahn, S., Marsden, C. D. and Calne, D. B.:Classification and investigation of dystonia. In:Movement Disorders 2, ed. by Marsden, C.D. and Fahn, S., Butterworths, London, 1987, pp. 332-358

• 3) 柳澤信夫:特発性捻転ジストニー. 神経研究の進歩 39:488-496, 1995

P.83 掲載の参考文献

• 1) Age-Related Dopamine-Dependent Disorders, ed, by Segawa, M. and Nomura, Y., vol 14, Monograph in Neural Science, Karger, Basel, 1995

• 2) Hereditary Progressive Dystonia, ed. by Segawa, M., The Parthenon Publishing Group, Carnforth and New York, 1993

P.86 掲載の参考文献

• 1) Seeman, P.:Dopamine receptors clinical correlates. In:Psychopharmacology, The Fourth Generation of Progress, ed. by Bloom, F. E. and Kupfer, D. J., Raven Press, New York, 1995, pp. 295-302

• 2) Meador-Woodruff, J. H., Damask, SK., Wang, J. et al.:Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology 15:17-29, 1996

• 3) Xu, M., Moratalla, R., Gold, LH. et al.:Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79:729-242, 1994
  pubmed

• 4) Xu, M., Hu, X.-T., Coper, D.C. et al.:Elimination of:cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 79:945-955, 1994

• 5) Yamaguchi, H., Aiba, A., Nakamura, K. et al.:Dopamine D2 receptor plays a critical role in cell proliferation and proopiomelanocortin expression in the pituitary. Genes to Cells 1:253-268, 1996

• 6) Baik, J. H., Picetti, R., Saiardi, A. et al.:Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377:424-428, 1995
  pubmed

• 7) Accili, D., Fishburn, C.S., Drago, J. et al.:A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc. Natl. Acad. Sci. USA 73:1945-1949, 1996

• 8) Pugsley, T. A., Whetzel, S., Corbin, A.E. et al.:Dopamine synthesis is increased in mice lacking dopamine D4 receptors. Soc. Neurosci. 22:523, 1996

P.89 掲載の参考文献

• 1) 小川紀雄:L-DOPAおよびドパミンアゴニストによる治療の実際. 日内会誌 83:575-580, 1994

• 2) Ogawa, N.:Levodopa and dopamine agonists in the treatment of Parkinson's disease:advantages and disadvantages. Eur. Neurol. 34 (suppl. 3):20-28, 1994

P.91 掲載の参考文献

• 1) Giros, B., Jaber, M., Jones, S.R. et al.:Hyper-locomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612, 1996

• 2) Goldman, D.:Dopamine transporter, alcoholism and ther diseases. Nature Med. 1:624-625, 1995

• 3) Kawarai, T., Kawakami, H., Yamamura, Y. et. al.:Structure and organization of the gene encoding human dopamine transporter. Gene (in press)

P.93 掲載の参考文献

• 1) 祖父江逸郎, 千田康博, 平山恵造ほか:Shy-Drager症候群および関連疾患に対するL-threo-3, 4-dihydroxyphenylserine (L-DOPS) の薬効評価. 医学のあゆみ141:353-378, 1987

• 2) 楢林博太郎, 中西孝雄, 吉田充男ほか:パーキンソン病におけるL-DOPSの治療効果. 臨床評価15:423-457, 1987

• 3) Narabayashi, H., Yokochi, F, Ogawa, T. et al.:Analysis of the effects of L-threo-DOPS on motor and psychological symptoms in Parkinson's disease. In:Norepinephrine Deficiency, ed. by Narabayashi, H. and Mizuno, Y., Parthenon, Lancs, 1993 pp. 105-115

• 4) 吉川隆子, 池田修一, 柳澤信夫ほか:家族性アミロイドポリニューロパチーの自律神経障害に対する L-DOPS療法の検討. 自律神経 24:113-120, 1987

P.95 掲載の参考文献

• 1) 田丸冬彦, 柳澤信夫:パーキンソン病の知的機能障害. 脳と神経 43:731-740, 1991

• 2) 特集:パーキンソン病と症候性パーキンソニズム-診断と治療のポイント-. 治療76:2-149, 1994

P.97 掲載の参考文献

• 1) Barbeau, A. et al.:Defective 4-hydroxylation of debrisoquine is a marker for genetic susceptibility in Parkinson's disease. Lancet ii:1213-1216, 1985

• 2) 近藤喜代太郎:遺伝学からみたパーキンソン病. 神経精神薬理 10:351-355, 1988

• 3) 近藤喜代太郎:パーキンソン病における環境と遺伝の交絡. 神経研究の進歩 33:759-765, 1989

• 4) 近藤喜代太郎:パーキンソン病の病因;危険要因研究の動向. 病態生理 14:313-318, 1995

• 5) Liou, H.-H. et al.:Environmental risk factors and Parkinson's disease;a case-control study in Taiwan. Nezarology 46(suppl.):A 349, 1996

P.99 掲載の参考文献

• 1) Polymeropoulos, M. H., Higgins, J. J., Golbe, L. I. et al.:Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 274:1197-1201, 1996
  pubmed

• 2) Vieregge, P.:Genetic factors in the etiology of idiopathic Parkinson's disease. J. Neural. Transm. 8:1-37, 1994

P.101 掲載の参考文献

• 1) Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed., ed. by Hardman, J. G. and Limbird, L. E., McGraw-Hill, New York, 1996

P.103 掲載の参考文献

• 1) The Huntington's Disease Collaborative Research Group:A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983, 1993

• 2) Duyao, M., Ambrose, C., Myers, R. et al.:Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genet. 4:387-392, 1993
  pubmed

• 3) Nasir, J., Floresco, S. B., O'Kusky, J. R. et al.:Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81:811-823, 1995
  pubmed

• 4) Mangiarini, L., Sathasivam, K., Seller, M. et al.:Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493-506, 1996

P.105 掲載の参考文献

• 1) Snow, B.J., Nygaard, T. G., Takahashi, H. et al:PET studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism. Ann. Neurol. 34:733-738, 1993

• 2) Takahashi, H., Snow, B. J., Nygaard, T. G. et al.:Fluorodopa PET scans of juvenile parkinsonism with prominent dystonia in relation to dopa-responsive dystonia. In:Age-Related Dopamine-Dependent Disorders, ed. by Segawa, M. and Nomura, Y., Monogr. Neural. Sci. 14, Karger, Basel, 1995, pp. 87-94

• 3) Nygaard, T. G., Takahashi, H., Heiman, G. A. et al.:Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia. Ann. Neurol. 32:603-608, 1992

• 4) Takahashi, H., Levine, R. A., Galloway, M. P. et al.:Biochemical and fluorodopa positron emission findings in an asymptomatic carrier of the gene for dopa-responsive dystonia. Ann. Neurol. 35:354-356, 1994

P.107 掲載の参考文献

• 1) Albert, M. L., Feldman, R. G. and Willis, A. L:The 'subcortical dementia' of progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatry 37:121-130, 1974
  pubmed

• 2) Cummings, J. L. and Benson, D. F.:Subcortical Dementia. Review of an emerging concept. Arch. Neurol. 41:874-879, 1984
  pubmed

• 3) Cummings, J. L. and Benson, D. F.:Subcortical mechanisms and human thought. In:Subcortical Dementia, ed. by Cummings, J. L., Oxford University Press, New York, 1990, pp. 251-259

P.109 掲載の参考文献

• 1) 葛原茂樹, 吉村正博, 名倉博史ほか:汎発性Lewy小体病の臨床症状に関する研究. 8症例の報告と文献例の検討. 臨床神経 28:1274-1281, 1988

• 2) Kosaka, K:Diffuse Lewy body disease in Japan. J. Neurol. 237:197-204, 1990
  pubmed

• 3) McKeith, I.G., Galasko, D., Kosaka, K. et al.:Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB):report of the consortium on DLB international workshop. Neurology 47:1113-1124, 1996

P.111 掲載の参考文献

• 1) Limbic Motor Circuits and Neuropsychiatry. ed. by Kalivas, P. W. and Barnes, C. D., CRC Press, London 1993, pp. 1-88, pp. 237-287

• 2) Motor and Cognitive Functions of the Prefrontal Cortex. ed. by Thierry, A.-M. Glowinski, J., Goldman-Rakic, P.S. et al., Springer-Verlag, Berlin, 1994, pp. 51-77

P.113 掲載の参考文献

• 1) 梶龍兒, 目崎高広:ジストニアとボツリヌス治療. 診断と治療社, 東京, 1996

• 2) Anderson, R. L, Blitzer, A., Brin, M.F. et al.:Training guidelines for the use of botulinu toxin for the treatment of neurologic disorders. Neurology 44:2401-2403, 1994

P.115 掲載の参考文献

• 1) Sakai, T., Mawatari, S., Iwashita, H. et al:Choreoacanthocytosis. Clues to clinical diagnosis. Arch. Neurol. 38:335-338, 1981
  pubmed

• 2) Brin, M.F.:Acanthocytosis. In:Handbook Clinical Neurology, Vol. 19 (63), Systemic diseases, Part I. ed. by Goetz, C.G., Tanner, C.M. and Aminoff, M.J., Elsevier Amsterdam, 1993, pp. 271-299

• 3) Takashima, H., Sakai, T., Iwashita, H. et al.:A family of McLeod syndrome, masquerading as chorea-acanthocytosis. J. Neurol. Sci. 124:56-60, 1994
  pubmed

2. 小脳性疾患

P.119 掲載の参考文献

• 1) Victor, M., Adams, R.D. and Mancall, E.L.:A restricted form of cerebellar cortical degeneration occurring in alcoholic patients. Arch. Neurol. 1:579-688, 1959

• 2) Victor, M. and Martin, J.B.:Nutritional and metabolic diseases of the nervous system. In:Harrison's Textbook of Internal Medicine, vol. 2, 13th ed., ed. by Isselbacher, K.J. Braunwald, E., Wilson, J. D. et al., McGraw-Hill, New York, 1994, pp. 2328-2329

• 3) 高須俊明:アルコール性脳神経障害. 医学のあゆみ 54:943-946, 1990

P.121 掲載の参考文献

• 1) Victor, M., Adams, R.D. and Collins, G. H.:The Wernicke-Korsakqff Syndrome. FA Davis, Philadelphia, 1971

• 2) Victor, M. and Martin, J.B.:Nutritional and metabolic diseases of the nervous system. In:Harrison's Textbook of Internal Medicine, vol. 2, 13th ed., by Isselbacher, K.J. et al., McGraw-Hill, New York, 1994, pp. 2328-2339

• 3) Wilson, J.D.:Vitamin deficiency and excess, McGraw-Hill, New York, 1994 pp. 474-475

• 4) 志方えりさ, 塩澤友規, 田村正人ほか:消化管手術後, 経口摂取開始早期に発症した Wernicke 脳症の2症例. 臨床外科 51:393-398, 1996

P.123 掲載の参考文献

• 1) Koskiniemi, M. L.:Baltic Myoclonus. In:Advances in Neurology, vol 43:Myoclonus, ed. by Fahn, S., Marsden, C. D., Van Woert, M. H., Raven Press, New York, 1986, pp. 57-64

• 2) Berkovic, S. F., Cochius, J., Andermann, E. et al.:Progressive myoclonus epilepsies:clinical and genetic aspects. Epilepsia 34(suppl. 3):S19-S30, 1993

• 3) Pennacchio, L. A., Lehesjoki, A-E., Stone, N. E. et al.:Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271:1731-1734, 1996
  pubmed

P.124 掲載の参考文献

• 1) Orzechowski, K.:De l'ataxie dysmetrique des yeux. Remarques sur l'ataxie des yeux dite myoclonique (opsoclonie, opsochorie). J. Psychol. Neurol. 35:1-18, 1927

• 2) Pranzatelli, M.R.:The neurobiology of the opsoclonus-myoclonus syndrome. Clin. Neuropharmacol. 15:186-228, 1992
  pubmed

• 3) 長井篤, 小林祥泰, 山下一也ほか:肺小細胞癌の遠隔効果によると思われる opsoclonus の1剖検例. 神経眼科 8:378-384, 1991

P.127 掲載の参考文献

• 1) 村田顕也, 高柳哲也:わが国の脊髄小脳変性症 (外国との比較についても) . Annual Review神経 1996, 中外医学社, 東京, 1996, pp. 323-335

• 2) 高柳哲也:脊髄小脳変性症治療の展望. 神経治療 10:185-192, 1993
  Medical*Online

• 3) 高柳哲也, 柳本真市:オリーブ橋小脳萎縮症の経過と予後. 神経治療 9:5-11, 1992
  Medical*Online

P.129 掲載の参考文献

• 1) 田中恵子:腫瘍随伴性小脳変性症. 最新医学 50:484-489, 1995
  Medical*Online

• 2) 中野亮一, 佐藤修三:Paraneoplastic cerebellar degeneration. 日本臨淋 52:212-217, 1994

P.131 掲載の参考文献

• 1) 福原信義:急性小脳炎 (成人) . 神経内科 27:6-10, 1987

• 2) Klockgeter, T., Doller, G., Wuller, U. et al.:Cerebellar encephalitis in adults. J. Neurol. 240:17-20, 1993

• 3) Iester, A., Alpigiani, M. G. and Franzone, G.:Magnetic resonance imaging in right hemisphere cerebellitis associated with homolateral hemiparesis child's. Nerv. Syst. 11:118-120, 1995

P.133 掲載の参考文献

• 1) 立石潤:プリオン病の診断基準・病型分類・重症度. 内科 75:1396-1398, 1995

• 2) Kuzuhara, S., Kanazawa, I., Sasaki, H. et al.:Gerstmann-Straussler-Scheinker's disease. Ann. Neurol. 14:216-225, 1983
  pubmed

• 3) 宇高不可思, 西中和人, 亀山正邦:Gerstmann-Straussler-Scheinker症候群. 神経内科 41:15-22, 1994

P.135 掲載の参考文献

• 1) 内藤明彦:進行性ミオクローヌスてんかんとDRPLA. 神経進歩 16:56-67, 1990

• 2) 池内健, 辻省次:Triplet repeat 異常と遺伝性神経筋疾患. Annual Review神経 1995, 後藤文男, 高倉公朋, 木下真男ほか編, 中外医学社, 東京, 1995, pp. 1-12

• 3) Ikeuchi, T., Koide, R., Onodera, O. et al.:Dentatorubral-pallidoluysian atrophy (DRPLA):molecular basis of wide clinical features of DRPLA. Clin. Neurosci. 3:23-27, 1995
  pubmed

P.137 掲載の参考文献

• 1) Macdonell, R.A.L, Kalnins, R.M. and Donnan, G.A.:Cerebellar infarction:natural history, prognosis and pathology. Stroke 14:849-855, 1987

• 2) Amarenco, P.:The spectrum of cerebellar infarctions. Neurology 41:973-979, 1991
  pubmed

P.139 掲載の参考文献

• 1) Meyers, S. P., Kemp, S.S. and Tarr, R.W.:MR imaging features of medulloblastomas. Am. J. Roentgenol. 158:859-865, 1992

• 2) Lee, S.R., Sanches, J., Mark, A.S. et al.:Posterior fossa hemangioblastomas;MR imaging. Radiology 171:463-468, 1989
  pubmed

• 3) Williams, D.W., Elster, A. D., Gingsberg, L.E et al. Recurrent Lhermitte-Duclos of two cases and association with Cowden'disease. Am. J. Neuro. Rad. 13:287-290,1992

P.141 掲載の参考文献

• 1) Amarenco, P.:The spectrum of cerebellar infarctions. Neurology 41:973-979, 1991
  pubmed

• 2) De Coene, B., Hajnal, J. V., Gatehouse, P. et al.:MR of the brain using fluid-attenuated inversion recovery (FLAIR) pulse sequences. AJNR 13:1555-1564, 1992
  pubmed

• 3) 小島重幸:脊髄小脳変性症の画像診断. 脳神経 47:35-42, 1995

P.143 掲載の参考文献

• 1) 田崎義昭, 斉藤佳雄:小脳機能の診かた. ベッドサイドの神経の診かた, 南山堂, 東京, 1987, pp. 126-139

• 2) 田代邦雄:失調. medicina 29:2216-2220, 1992

• 3) 田代邦雄:失調. medicina 29:2216-2220, 1992

P.145 掲載の参考文献

• 1) 中馬孝容, 真野行生, 高柳哲也:老年者の脊髄小脳変性症と歩行障害. 老化と疾患 7:206-211, 1994

• 2) 安東範明:運動失調の症候分析. 脳神経 47:15-21, 1995

• 3) Ugawa, Y., Hanajima, R. Kanazawa, I et. al.:Magnetic stimulation over the cerebellum in humans. Ann. Neurol. 37:703-713, 1995

P.149 掲載の参考文献

• 1) 金谷春之:小脳出血. 脳卒中 9:575, 1987

• 2) Ott, K. H., Kase, C.S, Ojemann, R.G. et al.:Cerebellar hemorrhage:diagnosis and treatment. A review of 56 cases. Arch. Neurol. 31:160, 1974
  pubmed

• 3) Fisher, C.M., Picard, E.H., Polak, A. et al.:Acute hypertensive cerebellar hemorrhage:diagnosis and surgical treatment. J. Nerv. Ment. Dis. 140:38-57, 1965
  pubmed

• 4) Heros, R.C.:Cerebellar hemorrhage and infarction. Stroke 13:106, 1982
  pubmed

P.151 掲載の参考文献

• 1) Burger, P.C. and Scheithauer, B.W.:Atlas of Tumor Pathology, Tumors of the Central Nervous System, Armed Forces Institute of Pathology, Washington, 1993

• 2) 松谷雅生:脳腫瘍 (第2版), 篠原出版, 東京, 1996

P.153 掲載の参考文献

• 1) 田代邦雄:失調. medicina 29:2216-2220, 1992

• 2) 栗原照幸:神経学的診察と検査の進め方. medicina 29:2158-2177, 1992

P.155 掲載の参考文献

• 1) 加瀬学:小脳障害に伴う眼球運動障害. 眼科大系(7) 神経眼科, 加瀬学, 清澤源弘, 向野和雄編, 中山書店, 1995, pp. 529-535

• 2) 佐藤悠:小脳による眼球運動制御機構. 神経眼科 12:381-389, 1995

P.157 掲載の参考文献

• 1) Altman, N. R., Naidich, T. P. and Braffman, B. N.:Posterior fossa malformations. AJNR 13:691-724, 1992

• 2) Barkovich, A. J., Kjos, B. O., Norman, D. et al.:Revised classification of posterior fossa cysts and cystlike malformations based on the results of multiplanar MR imaging. AJNR 10:977-988, 1989

• 3) 森惟明, 半田肇:新版先天異常の臨床と CT. にゅーうん社, 東京, 1990, pp. 130-164

P.159 掲載の参考文献

• 1) Ghez, C.:The Cerebellum. In:Principles Of Neural Science. 3rd ed., ed. by Kandel E.R., Schwartz J. H., and Jessell, T.M., Elsevier, New York, 1991, pp. 626-646

• 2) Adams, R.D., Victor, M. and Ropper, A.H.:Principles Of Neurology, 6th ed., McGraw-Hill, New York, 1997, pp. 84-93

• 3) Altman, J. and Bayer, S.A.:Development Of the Cerebellar System in Relation to its Evolution, Structure, and Functions. CRC Press, Boca Raton, 1997, pp. 1-79

P.161 掲載の参考文献

• 1) Radiology of the Skull and Brain, Volume 2, Book 2, Arteries, ed. by Newton, T. H. and Potts D. G., C. V. Mosby Company, Saint Luis, 1974, pp. 1659-1848

P.163 掲載の参考文献

• 1) Orr, H.T., Chung, M.-Y., Banfi, S. et al.:Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genet. 4:221-226, 1993
  pubmed

• 2) Goldfarb, L.G, Vasconcelos, O., Platonov, F. A. et al.:Unstable triplet repeat and phenotypic variability of spinocerebellar ataxia type 1 Ann. Neurol. 39:500-506, 1996
  pubmed

• 3) Servadio, A., Koshy, B., Armstrong, D. et al.:Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nature Genet. 10:94-98, 1995
  pubmed

P.165 掲載の参考文献

• 1) Orozco, D. G., Nodarse, F. A., Cordvese, S. R. et al.:Autosomal dominant cerebellar ataxia:clinical analysis of 263 patients from a homologeneous population in Holgin. Cuba Neurology 40:1369-1375, 1990

• 2) Pulst, S.-M., Nechiporuk, A., Nechiporuk, T. et al.:Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nature Genet. 14:269-276, 1996
  pubmed

• 3) Imbert, G., Saudou, F., Yvert, G. et al.:Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nature Genet. 14:285-291, 1996
  pubmed

• 4) Sanpei, K., Takano, H., Igarashi, S. et al.:Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nature Genet. 14:277-284, 1996
  pubmed

P.167 掲載の参考文献

• 1) Scriver, C. R., Beaudet, A. R., Sly, W. S. et al. (eds):The Metabolic and Molecular Bases of Inherited Disease, 7th ed, McGraw-Hill, New York, 1995

P.169 掲載の参考文献

• 1) Fukuhara, N.:Clinicopathological features of MERRF. Muscle Nerve (suppl.) 3:S90-S94, 1995
  pubmed

• 2) 福原信義:ミトコンドリア異常を伴う神経疾患. 神経疾患の遺伝学, 近藤喜代太郎, 鈴木義之編, 金原出版, 東京, 1993, pp. 170-186

• 3) 福原信義:myoclonus epilepsy associated with ragged-red fibers (MERRF). 最新内科学大系, 11巻, 井村裕夫ほか編, 中山書店, 東京. 1996, pp. 44-50

P.171 掲載の参考文献

• 1) Flanigan, K., Gardner, K., Alderson, K. et al.:Autosomal dominant spinocerebellar ataxia with sensory axonal neuropathy (SCA4):clinical description and genetic localization to chromosome 16q22. 1. Am. J. Hum. Genet. 59:392-399, 1996
  pubmed

• 2) Ranum, L.P. W., Schut, L.J., Lundgren, J.K. et al.:Spinocerebellar ataxia type 5 in a family descended from the grandparents of President Lincoln maps to chromosome 11. Nature Genet. 8:280-284, 1994

P.173 掲載の参考文献

• 1) 高柳哲也:脊髄小脳変性症. 日内会誌 82:57-60, 1993

• 2) Hirayama, K., Takayanagi, T., Nakamura, R. et al.:Spinocerebellar degenerations in Japan. Acta Neurol. Scand. (suppl. 153) 89:1-22, 1994

• 3) Matsumura, R., Takayanagi, T., Murata, K. et al.:Autosomal dominant cerebellar ataxias in the Kinki area of Japan. Jpn. J. Hum. Genet. 41:399-406, 1996
  pubmed

P.174 掲載の参考文献

• 1) Scriver, C. R., Beaudet, A. L, Sly, W. S. et al. (eds) The Metabolic Basis of lnherited Disease (vol. I, II). 6th ed. McGraw-Hill, New York, 1989

• 2) 垂井清一郎, 多田啓也編:遺伝子病マニュアル (上下巻), 中山書店, 東京, 1996

P.177 掲載の参考文献

• 1) 加藤雄司:中毒性・外因性小脳萎縮症の各種 (水銀を除く, 人を中心に) . 神経進歩 21:91-92, 1977

• 2) 内野誠, 二塚信:水俣病の今日. Brain Medical 8:163-168, 1996

• 3) 森文秋, 高屋豪瑩, 吉田泰二ほか:チオフェンによって惹起されたラット小脳血管障害. J. Toxicol. Pathol. 5:21-28, 1992
  Medical*Online

P.179 掲載の参考文献

• 1) Rowland, L.P.:Meritt's Textbook of Neurology, 9th edition, Williams and Wilkins, New York, 1995, pp. 557-558

• 2) Vesa, J., Hellsten, E, Verkruyse, L.A. et al.:Mutation in the palmitoyl thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376:584-587, 1995
  pubmed

• 3) 江崎淳二, 木南英紀:Batten病. 日本臨牀 53:3055-3061, 1995
  Medical*Online

P.181 掲載の参考文献

• 1) 栗山勝:脳腱黄色腫症. 最新内科学大系 69, 中山書店, 東京, 1996, pp. 59-69

• 2) 栗山勝:Cerebrotendinous xanthomatosis 1. 報告例153症例の臨床症候.神経内科 34:653-670,1991

P.183 掲載の参考文献

• 1) 柳本真市, 高柳哲也, 平山恵造ほか:わが国における晩発性小脳皮質萎縮症の臨床症候の多変量解析による検討. 臨床神経 32:951-955, 1992

• 2) Tsuchiya, K., Ozawa, E., Saito, F. et al.:Neuropathology of late cortical cerebellar atrophy in Japan:distribution of cerebellar change on an autopsy case and review of Japanese cases. Europ Neurol. 34:253-262, 1994

• 3) Ishikawa, K., Mizusawa, H., Saito, M. et al.:Autosomal dominant cerebellar ataxia:a clinical and genetic analysis of eight Japanese families. Brain 119:1173-1182, 1996
  pubmed

• 4) Zuchenko, O., Bailey, J., Bonnen, P. et al.:Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel Nature Genet. 15:62-69, 1997

• 5) 水澤英洋, 石川欽也, 斉藤正明ほか:遺伝性皮質性小脳萎縮症の分子遺伝学的研究-我が国には第19番染色体短腕p1913.1-p13.2に遺伝子座を有する病型が存在する-. 文部省重点領域研究脳細胞選択死研究班平成8年度報告書, 1997

P.185 掲載の参考文献

• 1) Kayden, H.J.:The neurologic syndrome of vitamin E deficiency. Neurology 43:2167-2169, 1993
  pubmed

• 2) Ouachi, K., Arita, M., Kayden, H. et al.:Ataxia with isolated vitamin E deficiency is caused by mutations in the α-tocopherol transfer protein. Nature Genet. 9:141-145, 1996

P.187 掲載の参考文献

• 1) Berlit, P. and Rakicky, J.:The Miller Fisher syndrome;review of the literature. J. Clin. Neuro-ophthalmol. 12:57-63, 1992

• 2) Najim, Al-Din, S., Anderson, M., Eeg-Olofsson, et at.:Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia;areview. Acta Neurol Scand. 89:157-163, 1994

• 3) 結城伸泰:Campylobacter jejuni と自己免疫性神経疾患:ギラン・バレー症候群およびフィッシャー症候群の発症機序. 日本細菌学雑誌 50:991-1003, 1995

P.189 掲載の参考文献

• 1) Moser, H. W.:Adrenoleukodystrophy. Current Opinion Neurol. 8:221-226, 1995

• 2) 小池亮子, 辻省次, 宮武正:Adrenoleukodystrophy. Dementia 6:167-177, 1992

P.191 掲載の参考文献

• 1) Campuzano, V., Montermini, L., Molto, M. D. et al.:Friedreich's ataxia:autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423-1427, 1996
  pubmed

• 2) Filla, A., De Michele, G., Cavalcanti, F. et al.:The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am. J. Hum. Genet. 59:554-560, 1996
  pubmed

• 3) Carvajal, J. J., Pook, M. A., dos Santos, M. et al.:The Friedreich's ataxia gene encodes a novel phosphatidylinositol-4-phosphate 5-kinase. Nature Genet. 14:157-162, 1996
  pubmed

P.193 掲載の参考文献

• 1) Takiyama, Y., Nishizawa, M., Tanaka, H. et al.:The gene for Machado-Joseph disease maps to human chromosome 14q. Nature Genet. 4:300-304, 1993
  pubmed

• 2) Kawaguchi, Y., Okamoto, T., Taniwaki, M. et al.:CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32. 1. Nature Genet. 8:221-227, 1994

• 3) Takiyama, Y., Igarashi, S., Rogaeva, E. A. et al.:Evidence for inter-generational instability in the CAG repeat in the MJDI gene and for conserved haplotypes at flanking markers amongst Japanese and Caucasian subjects with Machado-Joseph disease. Hum. Mol. Genet. 4:1137-1146, 1995

P.195 掲載の参考文献

• 1) 小宮山純, 河村満, 平山恵造:Marinesco-Sjogren 症候群にみられる筋病変:成人症例における臨床像との関連を中心として. 臨床神経 25:1131-1140, 1985

• 2) Komiyama, A., Nonaka, I. and Hirayama, K.:Muscle pathology in Marinesco Sjogren syndrome. J. Neurol. Sci. 89:103-113, 1989
  pubmed

• 3) 小宮山純, 高橋竜哉, 長谷川修ほか:Marinesco-Sjogren症候群における運動機能と移動能力の推移-8家系14例の長期観察-. リハ医学 32:33-39, 1995

P.197 掲載の参考文献

• 1) Van Heycop Ten Ham, M. W.:Lafora disease. A form of progressive myoclonus epilepsy. In:Handbooke of Clinical Neurology, ed. by Vinken, P. J., Bruyn, G. W., Klawans, H.L et al., vol. 15, The epilepsies, North-Holland, Amsterdam, 1974, pp. 382-422

• 2) 内藤明彦, 小柳新策:進行性ミオクローヌスてんかん. 医学書院, 東京, 1989, pp. 25-48

• 3) Tsuda, H., Katsumi, Y., Michikazu, N. et al.:Cerebral blood flow and metabolism in Lafora disease. Clin. Neurol. 35:175-179, 1995

• 4) Shibasaki, H., Ikeda, A., Takahashi, N. et al.:Cortical reflex negative myoclonus. Brain 117:477-486, 1994

P.199 掲載の参考文献

• 1) Leigh, D.:Subacute necrotizing encephalomyelopathy in an infant. J. Neurol. Neurosurg. Psychiat. 14:216-221, 1951

• 2) Pincus, J. H.:Subacute necrotizing encephalomyelopathy (Leigh's disease):a consideration of clinical features and etiology. Dev. Med. Child Neurol. 14:87-101, 1972
  pubmed

• 3) Plaitakis, A., Whestsell, W. O. Jr, Cooper, J. R. et al.:Chronic Leigh disease:agenetic and biochemical study. Ann. Neurol. 7:304-310, 1980

• 4) 萬満, 小林陽之助:Leigh症候群. 最新内科学体系, 11巻, 井村裕夫ほか編, 中山書店, 東京, 1996, pp. 66-73

3. 運動ニューロン疾患

P.203 掲載の参考文献

• 1) Beckman, J.S. (阿部康二邦訳):The reactions of nitric oxide with superoxide in cerebral ischemic injury. 脳卒中 16:318-328, 1994

• 2) Abe, K, Aoki, M., Ikeda, M. et al.:Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn superoxide dismutase gene mutations. J. Neurol. Sci. 136:108-116, 1996
  pubmed

• 3) 阿部康二:運動ニューロン疾患とフリーラジカル. 神経内科 42:213-222, 1995

• 4) Abe, K., Pan, L.H., Watanabe, M. et al.:Induction of nitrotyrosine-like immunoreactivity in the lower motor neurons of ALS. Neurosci. Lett. 199:152-154, 1995
  pubmed

P.205 掲載の参考文献

• 1) Oppenheim, R. W.:Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:453-501, 1991
  pubmed

• 2) Houenou, L.J., Li, L., Lo, A.C. et al.:Naturally occurring and axotomy-induced motoneuron death and its prevention by neurotrophic agents:acomparison between chick and mouse. Prog. Brain Res. 102:217-226, 1994

• 3) Henderson, C.E.:Role of neurotrophic factors in neuronal development. Curr. Opin. Neurobiol. 6:64-70, 1996
  pubmed

• 4) 八木沼洋行:神経系の発生過程におけるプログラム細胞死. 神経進歩 40:173-186, 1996

P.207 掲載の参考文献

• 1) Bredesen, D.E.:Neural apoptosis. Ann. Neurol. 38:839-851, 1995
  pubmed

• 2) Gorman, A. M., McGowan, A., O:Neill, C. et al.:Oxidative stress and apoptosis in neurodegeneration. J. Neurol. Sci. 139 (suppl):45-52, 1996

• 3) 山崎峰雄, 中野今治:神経細胞のアポトーシス. 現代医療 29:93-98, 1997

P.209 掲載の参考文献

• 1) 磯崎英治, 林理之, 林田哲郎ほか:多系統萎縮症における声帯外転麻痺;睡眠中の声帯奇異性運動. 臨床神経 36:529-533, 1996

• 2) 磯崎英治, 宮本和人, 小山内龍一ほか:両側声帯麻痺を合併した多系統萎縮症23例における臨床的検討. 臨床神経 31:249-254, 1991

• 3) 斎藤豊和, 宮田嘉世子, 細田稔ほか:末梢神経障害を伴う家族性球脊髄性筋萎縮症;1家系2症例における腓腹神経の検討. 臨床神経 28:695-704, 1988

• 4) 富保和宏, 斎藤豊和, 糠澤達志ほか:両側声帯麻痺をきたした球脊髄性筋萎縮症例. 臨床神経 36:683-686, 1996

• 5) Young, I.D. and Harper, P.S.:Hereditary distal spinal muscular atrophy with vocal cord paralysis. J. Neurol. Neurosurg. Psychiat. 43:413-418, 1980
  pubmed

P.211 掲載の参考文献

• 1) 片口安史:ロールシャッハ分裂病得点. 心理学研究 28:273-281, 1957

• 2) 萱場悦子:神経症者のプラセボ効果に関する研究. 東京学芸大学大学院修士論文, 1987

• 3) 遠山尚孝ほか:不安感情-特性尺度 (STAI) に関する研究. 日本心理学会第40回大会論文集, 891-892, 1976

P.213 掲載の参考文献

• 1) Shaw, J. S.:Excitotoxicity and motor neuron disease:a review of the evidence. J. Neurol. Sci. 124(suppl.):6-13, 1994

• 2) Lipton, S. A. and Rosenberg, P. A.:Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330:613-622, 1994
  pubmed

• 3) Rothstein, J. D.:Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. In:Advances in Neurology Vol. 68, Pathogenesis and Therapy of Amyotrophic Lateral Sclerosis, ed. by Serratrice, G. and Munsat, T., Lippincott-Raven Publishers, Philadelphia, 1995, pp. 7-20

P.215 掲載の参考文献

• 1) Kondo, K:Epidemiological aspects of motor neuron disease, In:Amyotrophic Lateral Sclerosis:Progress and Perspectives in Basic Research and Clinical Application, ed. by Nakano, I. and Hirano, A., Elsevier Science B. V., Amsterdam, 1966, pp. 133-1412

• 2) Kurtzke, J. F.:Risk factors in amyotrophic lateral sclerosis. In:Advances in Neurology, Vol. 56:Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases, ed. by Rowland, L. P., Raven Press, New York, 1991, pp. 245-2703

• 3) 吉田宗平:1. 筋萎縮性側索硬化症 (ALS) -病型と遺伝・疫学的特徴 . NOとスーパーオキシドー臓器特性と分子病態-, IV. SOD と神経病態-. 井上正康, 佐藤英介, 谷口直之ほか編, 日本アクセル・シュプリンガー出版, 東京, 1995, pp. 122-127

P.217 掲載の参考文献

• 1) Weiner, W. J.:Respiratory dysfunction in neurologic disease. Futuba Publishers, New York, 1980

• 2) Shneerson, J. M.:Is chronic respiratory failure in neuromuscular diseases worth treating? J. Neurol. Neurosurg. Psych. 61:1-3, 1996

P.219 掲載の参考文献

• 1) 川村佐和子:筋・神経疾患における在宅人工呼吸器看護-15症例の経験から-. 神経進歩 34:231-237, 1990

• 2) 古和久幸:筋萎縮性側索硬化症の在宅医療. 神経治療 10:279-283, 1993
  Medical*Online

• 3) 近藤清彦:筋萎縮性側索硬化症の在宅療法および人工呼吸器装着の適応と実際上の注意は? 神経疾患の臨床-今日の論点, 柳澤信夫編著, 中外医学社, 東京, 1993, pp. 141-151

P.221 掲載の参考文献

• 1) Shimizu, T., Hayashi, H., Kato, S. et al.:Circulatory collapse and sudden death in respirator-dependent amyotrophic lateral sclerosis. J. Neurol. Sci. 124:45-55, 1994
  pubmed

• 2) Shimizu, T., Hayashi, H., Hayashi, M. et al.:Hyposensitivity of peripheral alpha-adrenoceptors in respirator-dependent amytrophic lateral sclerosis assessed by intravenous norepinephrine infusion. Clin. Auton. Res. 5:165-169, 1995

• 3) Shimizu, T., Kato, S., Hayashi, M. et al.:Amyotrophic lateral sclerosis with hypertensive attacks:blood pressure changes in response to drug administration. Clin. Auton. Res. 6:241-244, 1996
  pubmed

P.223 掲載の参考文献

• 1) 柳下章, 中野今治:皮質脊髄路と筋萎縮性側索硬化症-病理とMRI. 病理と臨床 12:843-851, 1994

• 2) 柳下章, 中野今治, 小田雅也:筋萎縮性側索硬化症の脳のMRI. 神経進歩 40:53-62, 1996

• 3) 井門ゆかり, 山口慎也, 片山禎夫ほか:MRIT2強調画像上の大脳皮質低信号域の検討. 日老会誌 31:697-704, 1994

P.225 掲載の参考文献

• 1) Kew, J. J. M., Goldstein, L. H., Leigh, P. N. et al.:The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsy-chological and positron emission tomography study. Brain 116:1399-1423, 1993

• 2) Kew, J. J. M., Brooks, D. J., Passingham, R. E. et al.:Cortical function in progressive lower motor neuron disorders and amyotrophic lateral sclerosis:acomparative PET study. Neurology 44:1101-1110, 1994

• 3) Abrahams, S., Leigh, P. N., Kew, J. J. M. et al.:A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis. J. Neurol. Sci. 129:44-46, 1995

P.227 掲載の参考文献

• 1) Ono, S., Toyokura, Y., Mannen, T. et al.:Amyotrophic lateral sclerosis;histologic, histochemical and ultrastructural abnormalities of skin. Neurology 36:948-956, 1986
  pubmed

• 2) Ono, S. and Yamauchi, M.:Collagen cross-linking of skin in patients with amyotrophic lateral sclerosis. Ann. Neurol. 31:305-310, 1992
  pubmed

• 3) Ono, S. and Yamauchi, M.:The amorphous material of skin in amyotrophic lateral sclerosis. Neurology 44:537-540, 1994
  pubmed

P.229 掲載の参考文献

• 1) Penfield, W. and Jasper, H.:Epilepsy and the Functional Anatomy of the Human Brain. Little Bown, Boston, 1954

• 2) 本多度夫:筋萎縮性側索硬化症の臨床評価スケール. 神経進歩 40:125, 1996

P.231 掲載の参考文献

• 1) 三本博:ALSの治療, その現況と将来. 神経治療学 10:519-526, 1993
  Medical*Online

• 2) Leigh, P. N. and Ray-Chaudhuri, K.:Motor neuron disease. J. Neurol. Neurosurg. Psychiat. 57:886-896, 1994
  pubmed

P.233 掲載の参考文献

• 1) 阿部康二:運動ニューロン疾患とフリーラジカル. 神経内科 42:213-222, 1995

• 2) Siddique, T. and Deng, H. X.:Genetics of amyotrophic lateral sclerosis. Hum. Mol. Genet. 5:1465-1470, 1996
  pubmed

P.235 掲載の参考文献

• 1) Shiraki, H. and Yase, Y.:Amyotrophic lateral sclerosis in Japan. In:Handbooke of Clinical Neurology, Vol. 22, System Disorders and Atrophies. Part II, ed. by Vinken, P. J. and Bruyn, G. W., Elsevier, Amsterdam, 1975, pp. 353-419

• 2) 八瀬善郎:筋萎縮性側索硬化症-般的傾向と西南多発地における疫学像-. 神経進歩 33:741-751, 1989

• 3) 吉田宗平, 紀平為子, 河本純子ほか:紀伊半島筋萎縮性側索硬化症 (ALS) の最近の疫学像-Migration study を中心として-. 神経内科 41:369-376, 1994

P.237 掲載の参考文献

• 1) Kennedy, W. R., Alter, M. and Sung, J. H.:Progressive proximal spinal and bulbar muscular atrophy of late onset:a sex-linked recessive trait. Neurology 18:671-680, 1968
  pubmed

• 2) 向井栄一郎, 満間照典, 高橋昭ほか:球脊髄性筋萎縮症の男性性腺機能不全と女性化徴候に関する内分泌学的検討. 臨床神経 24:925-929, 1984

• 3) Sobue, G., Hashizume, Y., Mukai, E. et al.:X-linked recessive bulbospinal neuronopathy:aclinicopathological study. Brain 112:209-232, 1989

P.239 掲載の参考文献

• 1) Sultan, C., Lumbroso, S., Poujol, N. et al.:Mutations of androgen receptor gene in androgen insensitivity syndromes. J. Steroid Biochem. Molec. Biol. 46:519-530, 1993
  pubmed

• 2) 道勇学, 祖父江元:伴性劣性球脊髄性筋萎縮症とアンドロゲン受容体遺伝子異常, アンドロゲン受容体遺伝子異常と細胞内情報伝達系. 神経内科 41:329-337, 1994

• 3) La Spada, A. R., Paulson, H. L. and Fischbeck, K. H.:Trinucleotide repeat expansion in neurological disease. Ann. Neurol. 36:814-822, 1994
  pubmed

P.241 掲載の参考文献

• 1) 小長谷正明, 酒井素子, 飯田光男ほか:著明な錐体路障害と前・側頭葉萎縮を呈した運動ニューロン疾患の1剖検例. とくに原発性側索硬化症との関係について. 臨床神経 35:384-390, 1995

• 2) Pringle, C. E., Hudson, A.J., Munoz, D. G. et al.:Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 115:495-520, 1992
  pubmed

P.243 掲載の参考文献

• 1) Oda, M., Akagawa, N, Tabuchi, Y. et al.:A sporadic juvenile case of the amyotrophic lateral sclerosis with neuronal intracytoplasmic inclusions. Acta Neuropathol. 44:211-216, 1978
  pubmed

• 2) Matsumoto, S., Kusaka, H., Murakami, N. et al.:Basophilic inclusions in sporadic juvenile amyotrophic lateral sclerosis:an immunocytochemical and ultrastructural study. Acta Neuropathol. 83:579-583, 1992
  pubmed

• 3) Kusaka, H., Matsumoto, S. and Imai, T.:An adult-onset case of sporadic motor neuron disease with basophilic inclusions. Acta Neuropathol. 80:660-665, 1990
  pubmed

P.245 掲載の参考文献

• 1) 木村文治:神経細胞死におけるアポトーシスの可能性について (II) . 診断と治療 83:127-136, 1995

• 2) Appel, S.H., Smith, R.G., Engelhardt, J.I et al.:Evidence for autoimmunity in amyotrophic lateral sclerosis. J. Neurol. Sci. 118:169-174, 1993
  pubmed

• 3) Smith, R.G., Hamilton, S., Hofmann, F. et al.:Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N. Engl. J. Med. 327:1721-1728, 1992

• 4) Kimura, F, Smith, R. G., Delbono, O. et al.:Amyotrophic lateral sclerosis:antibodies label Ca+ channel α1 subunit. Ann. Neurol. 35:164-171, 1994

P.247 掲載の参考文献

• 1) Yu, R. K., Yoshino, H. and Ariga, T.:The role of glycosphingolipids in peripheral neuropathy and related disorders. In:Glycobiology and the Brain, ed. by Nicolin, M. and Zatta, P. F, Pergamon Press, Oxford, 1993, pp. 155-177

• 2) 吉野英, 増田真之, 中谷雪ほか:筋萎縮性側索硬化症および運動性ニューロパチーにおける抗ガングリオシド抗体の検索と血漿交換による治療の試み. 医療 50:204-219, 1996

P.249 掲載の参考文献

• 1) Brady, S.:Motor-neuron diseases. Interfering with the runners. Nature 375:12-13, 1995
  pubmed

• 2) Shibata, N, Hirano, A., Kobayashi, M. et al.:Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J. Neuropathol. Exp. Neurol. 55:481-490, 1996
  pubmed

• 3) Ince, P. G., Shaw, P. J., Slade, J. Y. et al.:Familial amyotrophic lateral sclerosis with a mutation in exon 1 of the Cu/Zn superoxide dismutase gene:pathological and immunocytochemical changes. Acta Neuropathol. 88:185-188, 1996

• 4) Kato, S., Kawata, A., Oda, M. et al.:Absence of SOD1 gene abnormalities in familial amyotrophic lateral sclerosis with posterior column involvement without Lewy-body-like hyaline inclusions. Acta Neuropathol. 92:528-533, 1996
  pubmed

• 5) Kato, S., Shimoda, M, Watanabe, Y. et al.:Familial amyotrophic lateral sclerosis with a two base pair deletion in superoxide dismutase 1 gene:multisystem degeneration with intracytoplasmic inclusions in astrocytes. J. Neuropathol. Exp. Neurol. 55:1089-1101, 1996
  pubmed

P.251 掲載の参考文献

• 1) 中野今治:「運動ニューロン疾患の病理と病態」運動ニューロン疾患における神経細胞封入体の意義. 厚生省特定疾患, 神経変性疾患調査研究班, 1994年度報告書, 1995, pp. 241-246

• 2) Sasaki, S., Tsutsumi, Y., Yamane, K. et al.:Sporadic amyotrophic lateral sclerosis with extensive neurological involvement. Acta Neuropathol. 84:211-215, 1992
  pubmed

• 3) Takeda, S., Yamada, M., Kawasaki, K et al.:Motor neuron disease with multisystem involvement presenting as tetraparesis, opthalmoplegia and sesori-autonomic dysfunction. Acta Neuropathol. 88:193-200, 1994

P.253 掲載の参考文献

• 1) Hollmann, M. and Heinemann, S.:Cloned glutamate receptor. Annu. Rev. Neurosci. 17:31-108, 1994
  pubmed

• 2) Shaw, P.J.:Excitotoxicity and motor neuron disease:a review of evidence. J. Neurol. Sci. 124(suppl.):6-13, 1994

• 3) 郭伸:グルタミン酸受容体チャネルと変性性神経疾患 "イオンチャネルと疾患". 倉智嘉久編, 羊土社, 東京, 1993, pp. 94-105

P.255 掲載の参考文献

• 1) 村上俊一:筋萎縮性側索硬化症. 現代病理学大系 23B. 飯島宗一ほか編, 中山書店, 東京, 1993, pp. 109-166

• 2) Matsumoto, S., Kusaka, H., Murakami, N. et al.:Basophilic inclusions in sporadic juvenile ALS:an immunocytochemical and ultrastructural study. Acta Neuropathol. 83:579-583, 1992
  pubmed

• 3) Yokochi, K., Oda, M., Satoh, J. et al.:An autopsy case of atypical infantile motor neuron disease with hyaline intraneuronal inclusions. Arch. Neurol 46:103-107, 1989
  pubmed

P.257 掲載の参考文献

• 1) Munsat, T. and Davies, K. E.:Meeting report. International SMA Consortium Meeting. Neuromusc. Disord. 2:423-428, 1992
  pubmed

• 2) Lefebvre, S., Burglen, L., Reboullet, S. et al.:Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155-165, 1995
  pubmed

• 3) Roy, N., Mahadevan, M. S., McLean, M. et al.:The gene for neuronal apoptosis inhibitory protein is partially deleted individuals with spinal muscular atrophy. Cell 80:167-178, 1995
  pubmed

P.259 掲載の参考文献

• 1) 高橋良輔:筋萎縮性側索硬化症と栄養因子. 神経進歩 40:33-42, 1996

• 2) Yuen, E.C. and Mobley, W. C.:Therapeutic potential of neurotrophic factors for neurological disorders. Ann. Neurol. 40:346-354, 1996
  pubmed

P.261 掲載の参考文献

• 1) 八瀬善郎:筋萎縮性側索硬化症と金属代謝. 脳神経 34:7-15, 1982

• 2) Moriwaka, F., Satoh, H., Ejima, A. et al.:Mercury and selenium contents in amyotrophic lateral sclerosis in Hokkaido, the northernmost island of Japan. J. Neurol. Sci. 118:38-42, 1993
  pubmed

• 3) Kasarskis, E.J.:Neurotoxicology:heavy metals. In:Handbook of Amyotrophic Lateral Sclerosis, ed. by Smith, R.A., Marcel Dekkeer, New York, 1992, pp. 559-674.

P.263 掲載の参考文献

• 1) Taniguchi, N.:Clinical significance of superoxide dismutase;changes in aging, diabetes, ischemia, and cancer. Adv. Clin. Chem. 29:1-59, 1992

• 2) Brown, R.H. Jr.:Amyotrophic lateral sclerosis:recent insights from genetic and transgenic mice. Cell 80:687-692, 1995
  pubmed

• 3) 藤井順逸, Theingi Myint, 谷口直之:老化とアポトーシス;活性酸素中間体の関与する生命反応. 実験医学 (増刊) 13:2043-2047, 1995

P.265 掲載の参考文献

• 1) 丘村煕:嚥下機能の評価と診断. 嚥下のしくみと臨床. 金原出版, 東京, 1993, pp. 25-82

• 2) Montogomery, W. W.:Surgery to prevent aspiration. Arch. Otolaryngol. 101:679-682, 1975

• 3) 田山二朗, 村上泰, 水野正浩ほか:喉頭微細手術下シリコン注入による声門閉鎖術-内視鏡下声門閉鎖術-. 耳鼻と臨床39:395-398. 1993

P.267 掲載の参考文献

• 1) 園生雅弘:Fasciculationの起源と筋電図上の問題点. 神経研究の進歩 40:75-83, 1996

• 2) Layzer, R. B.:The origin of muscle fasciculations and cramps. Muscle Nerve 17:1243-1249, 1994
  pubmed

• 3) Bostock, H., Sharief, M. K., Reid, G. et al.:Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain 118:217-225, 1995
  pubmed

P.269 掲載の参考文献

• 1) 三山吉夫:Motor Neuron Diseaseを伴う初老期痴呆. Dementia 10:423-429, 1996

• 2) 村上信之:運動ニューロン疾患と痴呆. medicina 33:1881-1883, 1996

• 3) 村上信之, 吉田眞理:痴呆を伴う筋萎縮性側索硬化症臨床像・病理像の再評価. 臨床神経 35:1560-1562, 1995

P.271 掲載の参考文献

• 1) Xu, Z., Cork, L. C., Griffin, J. W. et al.:Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 73:23-33, 1993
  pubmed

• 2) Cote, F., Collard J. F. and Julien, J. P.:Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene, a mouse model of amyotrophic lateral sclerosis. Cell 73:35-46, 1993
  pubmed

• 3) Lee, M. K., Marzalek, J. R. and Cleveland, D. W.:A mutant neurofilament subunit causes massive selective motor neuron death, implications for the pathogenesis of human motor neuron disease. Neuron 13:975-988, 1994

P.273 掲載の参考文献

• 1) Barker, A. T., Jalinous, R. and Freeston, I. L.:Non-invasive magnetic stimulation of human motor cortex. Lancet i:1106-1107, 1985
  pubmed

• 2) 宇川義一:大脳・脊髄刺激法. 脳神経 43:1017-1023, 1991

• 3) Kano, M., Niijima, K., Fujimoto, Y. et al.:Dissociation of the thresholds of excitatory and inhibitory effects evoked by magnetic cortical stimulation in amyotrophic lateral sclerosis (ALS). Muscle Nerve (suppl.) 1:S161, 1994

P.275 掲載の参考文献

• 1) 平山恵造:若年性-側上肢筋萎縮症 (平山病). Annual Review 神経 1996, 後藤文男, 高倉公朋, 木下真男ほか編, 中外医学社, 東京, 1996, pp. 249-260

• 2) 平山恵造, 得丸幸夫:若年性-側上肢筋萎縮症. モダンコンセプト神経内科5, 田代邦雄, 水野美邦, 栗原照幸ほか編, 医学書院, 東京, 1995, pp. 85-95

P.277 掲載の参考文献

• 1) 岡本幸市:Bunina body. 神経研究の進歩 40:16-24, 1996

• 2) Okamoto, K.:Bunina bodies in amyotrophic lateral sclerosis. Neuropathology 13:193-199, 1993

P.279 掲載の参考文献

• 1) Bruijn, LI. and Cleveland, D. W.:Mechanisms of selective motor neuron death in ALS:insights from transgenic mouse models of motor neuron disease. Neuropathol. Applied Neurobiol. 22:373-387, 1996

• 2) Ludolph, A. C.:Animal models for motor neuron diseases:research directions. Neurology 47(suppl. 4):S228-232, 1996